Delivery Order SPE2DE23D0008-SPE2D626F7276
Award Date 10/30/25
Potential Completion Date 11/3/25
Potential Value $21K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Irvine, CA 92612, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $5,421.00 fixed-price delivery order contract by the Defense Logistics Agency Medical Supply Chain on July 21, 2025, for Natrelle Inspira SSM 210CC breast implants. The contract, which carries an ultimate completion date of July 23, 2025, will be performed at Allergan's facility in Irvine, California. This delivery order was awarded without set-aside designation, reflecting Allergan's status as the sole-source provider of these...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,614.00 fixed-price delivery order on September 19, 2025, for Natrelle Inspira SCM 445CC breast implants through the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The contract carries an ultimate completion date of September 23, 2025, and will be performed in Irvine, California. This delivery order was issued without set-aside designation, reflecting Allergan's sole-source supplier status for specialized...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $2,814.00 by the Defense Logistics Agency's Medical Supply Chain division on July 22, 2025, with an ultimate completion date of July 24, 2025. The contract covers the supply of Natrelle Inspira SCM 375CC breast implants and will be performed in Irvine, California. This award was made without set-aside designation, reflecting Allergan's position as a specialized supplier of these medical devices to federal...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $2,814.00 by the Medical Supply Chain division of the Defense Logistics Agency on July 24, 2025, for Natrelle Inspira SSM 445CC breast implants. This fixed-price delivery order with economic price adjustment represents a child award issued without set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical implants to the federal government. The order is scheduled...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 fixed-price delivery order with economic price adjustment on September 2, 2025, for Natrelle Inspira SCM 375CC breast implants. The contract, which carries an ultimate completion date of September 4, 2025, was funded by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical medical devices. The place of...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,495 fixed-price delivery order for NATRELLE TE Smooth 133S-MX-15-T breast implants on August 14, 2025, with an ultimate completion date of August 18, 2025. This contract was funded by the Medical Supply Chain division of the Defense Logistics Agency and will be performed in Irvine, California. The award carries no set-aside designation, reflecting Allergan's status as a sole-source provider of specialized breast implant...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order on September 11, 2025, by the Defense Logistics Agency's Medical Supply Chain division for 4569553905 Inspira SRF 385CC breast implants, valued at $1,110.00. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of September 25, 2025, and represents performance work to be completed at Allergan's facility in Irvine, California. The award utilizes no set-aside designation,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $4,014 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain division for Natrelle Inspira SCF 605CC breast implants. The contract is a fixed-price delivery order with economic price adjustment clause, with a completion date of September 4, 2025. The place of performance is located in Irvine, California. This award was made without a set-aside designation, reflecting Allergan's position as a specialized...
- The U.S. Department of Defense Medical Supply Chain, operating through the Defense Logistics Agency Troop Support Medical, awarded a $2,814 fixed-price delivery order with economic price adjustment to Allergan USA Inc. for Natrelle Inspira SCX 800cc breast implants. The delivery order, issued on September 11, 2025, with an ultimate completion date of September 25, 2025, represents a child order under one of Allergan's existing Indefinite Delivery Vehicles—specifically a $13.5 million IDV for...
- The U.S. Department of Defense Medical Supply Chain division awarded a $2,814.00 fixed-price delivery order to Allergan USA Inc. (a subsidiary of AbbVie Inc.) on May 30, 2025, for Natrelle Inspira SCF 385CC breast implants with an ultimate completion date of May 30, 2025. The delivery order will be performed in Irvine, California, and includes economic price adjustment provisions. This award was made without a set-aside designation, reflecting Allergan's status as the sole source for this...